S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
Log in
CVE:QPT

Quest PharmaTech Inc. (QPT.V) Stock Forecast, Price & News

C$0.17
-0.01 (-5.56 %)
(As of 11/27/2020 10:39 AM ET)
Add
Compare
Today's Range
C$0.17
Now: C$0.17
C$0.17
50-Day Range
C$0.12
MA: C$0.14
C$0.18
52-Week Range
C$0.06
Now: C$0.17
C$0.28
Volume4,000 shs
Average Volume29,786 shs
Market CapitalizationC$28.52 million
P/E Ratio0.27
Dividend YieldN/A
BetaN/A
Quest PharmaTech Inc., a biotechnology company, develops and commercializes antibody based immunotherapeutic products for cancer. The company focuses on combinatorial immunotherapeutic approaches to cancer by using monoclonal antibodies of the immunoglobulin G or E subclass in combination with chemotherapy/immune-adjuvant. Its lead product candidate is Oregovomab, a monoclonal antibody, which has completed Phase II clinical trial for the treatment of ovarian cancer. The company also owns the Photodynamic therapy technology for oncology and dermatology applications; and develops Mab AR 9.6 against truncated O-glycan on MUC16 for targeted cancer therapy applications. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.80 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-780-4481400
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$38,871.00
Cash FlowC$0.00 per share
Book ValueC$0.65 per share

Profitability

Miscellaneous

Market CapC$28.52 million
Next Earnings Date12/18/2020 (Estimated)
OptionableNot Optionable
C$0.17
-0.01 (-5.56 %)
(As of 11/27/2020 10:39 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive QPT News and Ratings via Email

Sign-up to receive the latest news and ratings for QPT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Quest PharmaTech Inc. (QPT.V) (CVE:QPT) Frequently Asked Questions

How has Quest PharmaTech Inc. (QPT.V)'s stock been impacted by Coronavirus?

Quest PharmaTech Inc. (QPT.V)'s stock was trading at C$0.11 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, QPT stock has increased by 54.5% and is now trading at C$0.17.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Quest PharmaTech Inc. (QPT.V)?

Wall Street analysts have given Quest PharmaTech Inc. (QPT.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Quest PharmaTech Inc. (QPT.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Quest PharmaTech Inc. (QPT.V)'s next earnings date?

Quest PharmaTech Inc. (QPT.V) is scheduled to release its next quarterly earnings announcement on Friday, December 18th 2020.
View our earnings forecast for Quest PharmaTech Inc. (QPT.V)
.

How were Quest PharmaTech Inc. (QPT.V)'s earnings last quarter?

Quest PharmaTech Inc. (QPT.V) (CVE:QPT) announced its earnings results on Thursday, September, 24th. The company reported $0.02 EPS for the quarter.
View Quest PharmaTech Inc. (QPT.V)'s earnings history
.

Who are some of Quest PharmaTech Inc. (QPT.V)'s key competitors?

What other stocks do shareholders of Quest PharmaTech Inc. (QPT.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Quest PharmaTech Inc. (QPT.V) investors own include Indiva Limited (NDVA.V) (NDVA), CME Group (CME) and Aphria (APHA).

Who are Quest PharmaTech Inc. (QPT.V)'s key executives?

Quest PharmaTech Inc. (QPT.V)'s management team includes the following people:
  • Dr. Ragupathy Madiyalakan, CEO & Director
  • Mr. Pierre Vermette, Chief Financial Officer
  • Mr. Thomas Woo, VP of Product Devel.
  • Mr. Roger Andrews, Head of Investor Relations & Corp. Communications
  • Mr. Douglas C. Bachman, VP of Corp. Devel. (Age 66)

What is Quest PharmaTech Inc. (QPT.V)'s stock symbol?

Quest PharmaTech Inc. (QPT.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "QPT."

How do I buy shares of Quest PharmaTech Inc. (QPT.V)?

Shares of QPT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Quest PharmaTech Inc. (QPT.V)'s stock price today?

One share of QPT stock can currently be purchased for approximately C$0.17.

How big of a company is Quest PharmaTech Inc. (QPT.V)?

Quest PharmaTech Inc. (QPT.V) has a market capitalization of C$28.52 million and generates C$38,871.00 in revenue each year.

What is Quest PharmaTech Inc. (QPT.V)'s official website?

The official website for Quest PharmaTech Inc. (QPT.V) is www.questpharmatech.com.

How can I contact Quest PharmaTech Inc. (QPT.V)?

Quest PharmaTech Inc. (QPT.V)'s mailing address is 8123 Roper Rd NW, EDMONTON, AB T6E 6S4, Canada. The company can be reached via phone at +1-780-4481400.

This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.